Inactive/Delisted stock
Quoin Pharmaceuticals Stock (NASDAQ:QNRX)
Previous Close
$9.22
52W Range
$5.01 - $54.95
50D Avg
$7.97
200D Avg
$14.91
Market Cap
$5.41M
Avg Vol (3M)
$195.19K
Beta
1.78
Div Yield
-
QNRX Company Profile
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.